FibroGen Cash from Investing (TTM) Analysis

FibroGen Inc (FGEN)

1.02 +0.04 (+3.63%) USD | NASDAQ | Apr 25, 16:00

1.00 -0.02 (-1.96%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	153.66M
September 30, 2023	144.51M
June 30, 2023	135.07M
March 31, 2023	166.66M
December 31, 2022	89.12M
September 30, 2022	37.46M
June 30, 2022	-129.48M
March 31, 2022	-204.32M
December 31, 2021	-426.97M
September 30, 2021	-232.64M
June 30, 2021	-11.63M
March 31, 2021	199.76M
December 31, 2020	452.49M
September 30, 2020	283.69M
June 30, 2020	337.60M
March 31, 2020	202.51M
December 31, 2019	120.02M
September 30, 2019	-317.80M
June 30, 2019	-559.78M

Date	Value
March 31, 2019	-563.91M
December 31, 2018	-522.12M
September 30, 2018	-39.27M
June 30, 2018	59.48M
March 31, 2018	61.76M
December 31, 2017	69.87M
September 30, 2017	40.75M
June 30, 2017	39.80M
March 31, 2017	24.97M
December 31, 2016	6.622M
September 30, 2016	4.031M
June 30, 2016	-4.762M
March 31, 2016	-5.361M
December 31, 2015	-5.868M
September 30, 2015	-134.46M
June 30, 2015	-130.84M
March 31, 2015	-114.95M
December 31, 2014	-107.29M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-559.78M

Minimum

Jun 2019

452.49M

Maximum

Dec 2020

23.15M

Average

120.02M

Median

Dec 2019

Cash from Investing (TTM) Benchmarks